COVID antibody drugs from Lilly and Regeneron won’t do much to boost their top lines: analysts arlene.weintraub Thu, […]
Month: November 2020
Generics players join pledge to rapidly scale access to COVID-19 drugs. But will pharma sign on? kblankenship Thu, […]
AstraZeneca’s Calquence fails COVID-19 study, joining the list of repurposed meds that have fallen short esagonowsky Thu, 11/12/2020 […]
Johnson & Johnson confident in 1B dose goal for COVID vaccine next year, looking ahead to 2022 fkansteiner […]
Researchers have completed a clinical trial suggesting that the antidepressant drug fluvoxamine may help prevent deterioration in COVID-19 […]
Researchers have identified a potential genetic target for treating an especially painful and invasive form of endometriosis.
UC San Francisco scientists have developed a single clinical laboratory test capable of zeroing in on the microbial […]
Even with decades of unprecedented development in computational power, the human brain still holds many advantages over modern […]
As many countries face new stay-at-home restrictions to curb the spread of covid-19, there are concerns that rates […]
The US election victory for Joe Biden and Kamala Harris brings new hope for science and healthcare.12 Rational […]